bpc 157 and tb 500 mix BPC-157 / TB-500 — Research Peptide Blend (Lyophilised, HPLC ≥99%) — Research Use Only BPC-157 + TB-500 Blend |

Dosing typically begins at a lower dose, suggested initiation of 20 units (0.2 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 14: Inject 20 units (0.2 mL) one time per week Weeks 58: Inject 40 units (0.4 mL) one time per week Weeks 912: Inject 70 units (0.7 mL) one time per week Weeks 1316: Inject 90 units (0.9 mL) one time per week Weeks 1720: Inject 120 units (1.2 mL) one time per week Week 21+: Inject 140 units (1.4 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs

Can BPC-157 replace medical treatment

CONTROLLABLE By turning the lid it is possible to seamlessly adjust and precisely control the flow

In the Phase 2 clinical trial (NEJM, 2023), retatrutide was administered subcutaneously at doses ranging from approximately 0.5 mg to 12 mg per week, with dose escalation under close medical supervision

Lipotropic Blend: These injections contain a carefully crafted lipotropic blend that includes methionine, inositol, and choline